SCHEMBL22693168

SCHEMBL22693168

C#C/C=C(C(\C#N)=C/C)/N1CCC(Nc2cc(C(=O)N3CCN(c4cc(F)c(F)cc4S(N)(=O)=O)CC3)c(C)cc2C)CC1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MTOR P42345 7/20 0.49
RPTOR Q8N122 7/20 0.49
MLST8 Q9BVC4 7/20 0.49
SLC6A9 P48067 8/20 0.33
SLC6A5 Q9Y345 1/20 0.33
CA12 O43570 2/20 0.33
CA1 P00915 2/20 0.33
CA2 P00918 2/20 0.33
CA9 Q16790 2/20 0.33
MEN1 O00255 1/20 0.32
PKM P14618 1/20 0.32
KMT2A Q03164 1/20 0.32
KCNH2 Q12809 1/20 0.32
FASN P49327 1/20 0.31
LMNA P02545 1/20 0.31
MAPT P10636 1/20 0.31
TSHR P16473 1/20 0.31
HTT P42858 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22693236 0.89 MTOR (0.51) MTORRPTORMLST8CA12CA1
SCHEMBL22693132 0.89 MTOR (0.45) MTORRPTORMLST8SLC6A9SLC6A5
SCHEMBL22693159 0.89 MTOR (0.51) MTORRPTORMLST8SLC6A9SLC6A5
SCHEMBL22693170 0.84 MTOR (0.54) MTORRPTORMLST8CA12CA1
SCHEMBL22693266 0.84 MTOR (0.71) MTORRPTORMLST8SLC6A9SLC6A5
SCHEMBL22693180 0.83 MTOR (0.56) MTORRPTORMLST8SLC6A9CA12
SCHEMBL22693188 0.83 MTOR (0.49) MTORRPTORMLST8CA12CA1
SCHEMBL22693225 0.82 MTOR (0.54) MTORRPTORMLST8CA12CA1
SCHEMBL22693156 0.82 MTOR (0.69) MTORRPTORMLST8SLC6A9SLC6A5
SCHEMBL22693268 0.81 MTOR (0.49) MTORRPTORMLST8MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10844013-B2 Phenyl amino piperidine mTORC inhibitors and uses thereof NAVITOR PHARMACEUTICALS, INC. (US) 2020-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10844013-B2 Phenyl amino piperidine mTORC inhibitors and uses thereof MTOR, RICTOR, RPTOR MTOR 1/4885RPTOR 3/4885MLST8 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.